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Mitochondria dysfunction has been reported in various
kidney diseases but how it leads to kidney fibrosis and
how this is regulated is unknown. Here we found that
mitochondrial uncoupling protein 2 (UCP2) was induced in
kidney tubular epithelial cells after unilateral ureteral
obstruction in mice and that mice with ablated UCP2 resisted
obstruction-induced kidney fibrosis. We tested this
association further in cultured NRK-52E cells and found that
TGF-b1 remarkably induced UCP2 expression. Knockdown
of UCP2 largely abolished the effect of TGF-b1, whereas
overexpression of UCP2 promoted tubular cell phenotype
changes. Analysis using a UCP2 mRNA-30-untranslated region
luciferase construct showed that UCP2 mRNA is a direct
target of miR-30e. MiR-30e was downregulated in tubular
cells from fibrotic kidneys and TGF-b1-treated NRK-52E cells.
A miR-30e mimic significantly inhibited TGF-b1-induced
tubular-cell epithelial–mesenchymal transition, whereas a
miR-30e inhibitor imitated TGF-b1 effects. Finally, genipin, an
aglycone UCP2 inhibitor, significantly ameliorated kidney
fibrosis in mice. Thus, the miR-30e/UCP2 axis has an
important role in mediating TGF-b1-induced
epithelial–mesenchymal transition and kidney fibrosis.
Targeting this pathway may shed new light for the future of
fibrotic kidney disease therapy.
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Renal fibrosis is a common response to chronic kidney
diseases, including various types of nephropathy, nephritis,
and other nephritic diseases, which eventually leads to
irreversible renal failure.1 The key feature of renal fibrosis is
the accumulation of myofibroblasts and extracellular matrix
deposition, which may be originated from local interstitial
fibroblasts, pericytes, bone marrow–derived circulating
fibrocytes, local mesenchymal stem cells, endothelium, and
injured epithelium. Among them, tubular epithelial cells have
been recognized as one of the important contributors to
extracellular matrix deposition.2,3 Under physiological
conditions, proximal tubular cells are densely packed with
mitochondria. Because fully differentiated kidney proximal
tubules have minimal glycolytic capacity, they have to rely
on mitochondrial metabolism to synthesize adenosine
triphosphate (ATP) and supply the energy for the active
transport of sodium ions out of the tubule.4,5 The limitation
of the restoration of cellular ATP concentration has a pivotal
role in overall cellular recovery.6
Mitochondria dysfunction is involved in a variety of renal
diseases, including acute kidney injury induced by ischemia
reperfusion7,8 and renal fibrosis.9–12 The uncoupling proteins
(UCPs) are members of mitochondrial anion-carrier
proteins, which are located on the mitochondrial inner
membrane. Their primary function is to transfer protons
from the internal membrane to the matrix of the
mitochondria, and reduce the driving force of ATP
synthase from catalyzing ATP synthesis.13–15 Uncoupling
protein 2 (UCP2) protein exists in many organs such as
spleen, pancreas, heart, lung, brain, kidney, liver, and
muscle.16 UCP2-DD genotype is a potential genetic marker
for predicting the progression of chronic renal failure among
North Indians.17 UCP2s may also be susceptibility loci for
chronic renal disease in Japanese individuals.18 Targeting
UCP2 has been reported to treat many diseases, including
global cerebral ischemia,19 metabolic syndrome,20 obesity,21
diabetes,22,23 and atherosclerosis24 in animal models.
However, the role and mechanisms of UCP2 in tubular-cell
extracellular matrix production and renal fibrosis remain
largely unknown.
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MicroRNAs (miRNAs) are a family of endogenous
noncoding RNA with 20–22 nucleotides in length. They are
able to induce degradation or repress translation of target
mRNAs. Many publications reported that miRNAs have a
critical role in regulating cellular events, including gene
expression, cell differentiation, proliferation, and apoptosis,
as well as in the pathogenesis of many diseases such as kidney
diseases.16 Joglekar et al.25 implicated the critical role of miR-
30 family in regulating cultured fetal human pancreatic islet
cell epithelial–mesenchymal transition (EMT).
In this study, we found that the expression of UCP2 was
upregulated while miR-30e was decreased significantly in
kidney tubular cells at day 3 and 7 after unilateral ureteral
occlusion (UUO). Transforming growth factor-b1 (TGF-b1)
treatment could upregulate UCP2 and downregulate miR-30e
expression in cultured NRK-52E cells. Further experiments
demonstrated that UCP2 was a target of miR-30e. Down-
regulation of miR-30e leads to UCP2 upregulation and
triggers tubular cell phenotype changes and kidney fibrosis.
RESULTS
UCP2 is induced in tubular epithelial cells in mice with
obstructive nephropathy
To explore whether UCP2 is induced in fibrotic kidneys, the
expression of UCP2 in obstructed kidneys was detected.
As shown in Figure 1a and b, UCP2 mRNA was significantly
upregulated in kidneys at day 3 and 7 after UUO. Western
blotting results showed that UCP2 expression was low in
normal kidneys, but obviously increased in the fibrotic
kidneys at day 3 after UUO (Figure 1c and d). Immunohis-
tochemical staining revealed that UCP2 protein expression
was largely induced and localized in the tubular cells at day 3
and 7 after UUO (Figure 1e).
UCP2 ablation attenuates tubular EMT and kidney fibrosis
after UUO
To further investigate the role of UCP2 in kidney fibrosis, age
and sex-matched UCP2 knockouts (UCP2  / ) and
wild-type mice (UCP2þ /þ mice) were done with UUO.
In wild-type mice, at day 7 after ureteral obstruction, kidneys
developed severe morphological lesions and extracellular
matrix accumulation (Figure 2b and f). However, the
renal morphology was much less disrupted in UCP2 /
mice (Figure 2d). Renal extracellular matrix deposition was
significantly decreased in UCP2 / mice (Figure 2h and i).
In UCP2 / mice, the abundance of fibronectin (FN) and
a-smooth muscle actin (a-SMA) proteins in kidneys after
ureteral obstruction were significantly lower than those in
UCP2þ /þ mice. The E-cadherin expression was largely
restored in UCP2 / kidneys after UUO (Figure 2j).
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Figure 1 | Uncoupling protein 2 (UCP2) is induced in tubular cells from kidneys with obstructive nephropathy. (a) Reverse transcriptase
PCR analysis of UCP2 mRNA expression in whole-tissue lysate of the sham and obstructed kidneys. (b) Quantitative real-time PCR analysis
reveals that UCP2 mRNA is upregulated after unilateral ureteral occlusion (UUO). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
detected as normalization (*Po0.05 compared with control; n¼ 5; mean±s.e.m. as shown). (c) Western blot shows UCP2 protein expression in
the obstructive kidneys at day 3 and 7 after UUO. b-Actin was probed to confirm equal loading. (d) Graphic presentation of the relative
abundance of UCP2 protein in kidneys (*Po0.05 compared with sham; n¼ 3; mean±s.e.m. as shown). (e) Representative
immunohistochemical staining images for UCP2 protein in normal and the obstructed kidneys at day 3 and 7 after UUO.
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These results indicate that ablation of UCP2 gene attenuated
tubular-cell extracellular matrix production and kidney
fibrosis in obstructive kidneys.
It is well known that TGF-b1 has a pivotal role in
promoting tubular-cell EMT and kidney fibrosis. To inves-
tigate whether UCP2 ablation may affect TGF-b1 signaling,
we detected TGF-b1 and TGF-b1 type I receptor expression
in the sham or UUO kidneys. Results showed that TGF-b1
expression was remarkably induced in the UUO kidneys from
both UCP2þ /þ and UCP2 / mice, but there was
no difference between the two groups (Figure 2k). TGF-b1
type I receptor and phosphorylated Smad3 were induced in
the obstructed kidneys, and both of them were attenuated in
UCP2 / UUO kidneys compared with UCP2þ /þ UUO
kidneys (Figure 2l). The above data indicate that TGF-b1
signaling was attenuated in the UCP2 / UUO kidneys
compared with UCP2þ /þ UUO kidneys.
At day 7 after UUO, the kidney tubular cell proliferation
revealed as Ki67-staining positive cells was similar, whereas
cell apoptosis was less, in UCP2 / UUO kidneys
compared with UCP2þ /þ UUO kidneys (Supplementary
Figures S1 and S2 online). We also detected the macrophage
infiltration by staining the kidney tissue with anti-F4/80, a
well-used macrophage marker. The results showed that very
few F4/80-positive cells could be found in both of the sham
kidneys. The macrophage infiltration was remarkably
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Figure 2 |Uncoupling protein 2 (UCP2) deletion protects against obstructive nephropathy in mice. (a–d) Representative hematoxylin and
eosin staining micrographs show kidney morphology in sham control (a, c) and fibrotic kidneys (b, d) at day 7 in UCP2 / (c, d) and
wild-type (a, b) mice. (e–h) Representative Masson–Trichrome staining images for kidneys at day 7 after unilateral ureteral occlusion (UUO) in
UCP2 / (h) and wild-type (f) mice. (i) Semiquantitative analysis of matrix deposition in each group (*Po0.05 compared with sham; n¼ 5;
#Po0.05 vs UUO in UCP2þ /þ mice; n¼ 5; mean±s.e.m. as shown). (j) Western blot shows fibronectin (FN), E-cadherin, and a-smooth muscle
actin (a-SMA) expression in the whole kidneys after UUO in UCP2 / and UCP2þ /þ mice. The samples were reprobed with anti-b-actin to
confirm equal loading. (k) Transforming growth factor-b1 (TGF-b1) protein level in the obstructed kidneys from UCP2þ /þ and UCP2 /
mice was determined by enzyme-linked immunosorbent assay (*Po0.05 compared with sham; n¼ 5; mean±s.e.m. as shown). (l) Western
blot shows TGF-b1 type I receptor and phosphorylated Smad3 abundance in the whole kidneys.
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increased in the UCP2þ /þ UUO kidneys. In UCP2 /
UUO kidneys, infiltrated macrophages was much less than
those in UCP2þ /þ kidneys (Supplementary Figure S3
online).
UCP2 induction mediates TGF-b1-induced extracellular
matrix production in NRK-52E cells
Because UCP2 expression was correlative with renal fibrosis
in UUO model as shown above, we then wanted to know
whether UCP2 is induced in cultured NRK-52E cells after
TGF-b1 treatment. UCP2 mRNA was increased at 6 h and
maintained at high level up to 24 h after TGF-b1 stimulation
(Figure 3a and b). Western blotting results showed that UCP2
protein expression was also upregulated at 12 h and reached
peak at 24 h after treatment (Figure 3c and d).
To verify the role of UCP2 in TGF-b1-induced tubular
damage in vitro, UCP2 small interfering RNA (siRNA) was
transfected into NRK-52E cells. As shown in Figure 4a, UCP2
siRNA transfection was able to efficiently downregulate
UCP2 expression and largely abolish TGF-b1-induced
a-SMA and FN mRNA upregulation and E-cadherin mRNA
downregulation (Figure 4c). Western blotting (Figure 4b) and
immunofluorescent staining (Figure 4d) revealed that
TGF-b1 treatment induced tubular cell EMT, whereas
knocking down UCP2 inhibited such effects. Together, it is
concluded that UCP2 induction mediates TGF-b1 promoted
signaling transduction and extracellular matrix production in
tubular cells.
To further investigate if UCP2 can sufficiently induce
tubular-cell extracellular matrix production, a UCP2 mam-
malian expression plasmid was transfected into NRK-52E
cells. As shown in Figure 5a and c, similar to TGF-b1
stimulation, NRK-52E cells with UCP2 overexpression
displayed a phenotypic conversion by loss of E-cadherin,
induction of a-SMA and FN expression. Pre-transfection of
UCP2 plasmid could also amplify TGF-b1-induced tubular
cell phenotype changes (Figure 5b and d). These findings
indicate that UCP2 is an important mediator for TGF-b1-
induced kidney tubular-cell extracellular matrix production.
MiR-30e regulates UCP2 expression in NRK-52E cells
Above data reveal that UCP2 has a critical role in mediating
TGF-b1-induced tubular-cell extracellular matrix produc-
tion, but then how it is regulated remains obscure.
Computational tools (TargetScan and PicTar) predicted the
existence of evolutionarily conserved binding sites for miR-
30e in the 30 untranslated region (UTR) of UCP2 (Figure 6a).
To demonstrate the role of miR-30e in regulating UCP2
expression in tubular cells, UCP2 30-UTR was fused into a
luciferase reporter plasmid, and transiently transfected into
NRK-52E cells along with pre-miR-30e, pre-control,
anti-miR-30e, and anti-control. Cells transfected with pre-
miR-30e decreased luciferase activity, but when 30-UTR was
mutated, there was no decrease in luciferase activity.
Although reduction of miR-30e expression by transfecting
anti-miR-30e into NRK-52E cells resulted in an induction of
luciferase activity, p30-UTR mutation had no effect on
luciferase activity (Figure 6b).
We next investigated the role of miR-30e on UCP2
expression. As shown in Figure 6c and d, transfection of miR-
30e mimic could significantly decrease TGF-b1-induced
UCP2 mRNA and protein expression at the concentration
of 10, 50, and 100 nM, whereas transfection of miR-30e
inhibitor alone could induce UCP2 mRNA and protein
expression (Figure 6e and f), which mimicked the effect of
TGF-b1. In conclusion, these results demonstrated that
miR-30e is able to directly regulate UCP2 expression in
kidney tubular cells.
MiR-30e/UCP2 axis is involved into TGF-b1-induced tubular
cell injury
To investigate the role of miR-30e in kidney fibrosis, we
examined the abundance of miR-30e in fibrotic kidney
induced by UUO. There were as many as 62 miRNAs
expressed variably in UUO kidneys compared with sham
controls. Among them, miR-30e was drastically decreased
after UUO in a time-dependent manner (Figure 7a).
Quantitative real-time PCR results indicated that miR-30e
expression was also decreased, which confirmed the micro-
array results (Figure 7b). In situ hybridization assay revealed
that miR-30e was constitutively expressed in proximal
tubular cells of normal kidneys and was markedly decreased
in tubular cells at day 7 after UUO (Figure 7c–f).
In cultured NRK-52E cells, miR-30e was significantly
decreased as early as 1 h after TGF-b1 treatment (Figure 8a).
To study whether Smad signaling is involved in TGF-b1-
induced miR-30e downregulation, Smad7 plasmid transfec-
tion was used to block Smad signaling. As shown in
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transforming growth factor-b1 (TGF-b1) treatment in NRK-52E
cells. NRK-52E cells were treated with 5 ng/ml of TGF-b1 for various
periods of time as indicated. (a) Reverse transcriptase PCR analysis for
UCP2 mRNA expression. (b) Quantitative real-time PCR analysis shows
UCP2 mRNA expression in NRK-52E cells. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was detected as normalization
(*Po0.05 compared with control; n¼ 3; mean±s.e.m. as shown).
(c) Western blot shows UCP2 expression in NRK-52E cells. The
samples were reprobed with anti-b-actin to confirm equal loading.
(d) Graphic presentation of relative abundance of UCP2 protein
(*Po0.05 compared with control; n¼ 3; mean±s.e.m. as shown).
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Figure 8b, compared with pcDNA3, Smad7 transfection in
NRK-52E cells could partially block TGF-b1-induced miR-
30e downregulation, which suggest that Smad signaling
activation has a role in regulating miR-30e expression.
To explore the role of miR-30e in tubular-cell extracellular
matrix production, NRK-52E cells were transfected with
miR-30e mimic or inhibitor. Figure 8e shows that miR-30e-
mimic transfection resisted to TGF-b1-induced damage in
NRK-52E cells, whereas miR-30e inhibitor promoted epithe-
lial cell phenotype changes viewed as loss of E-cadherin,
induction of a-SMA, and FN expression (Figure 8f).
To assess whether UCP2 induction mediates miR-30e-
regulated tubular cell EMT, miR-30e inhibitor and UCP2
siRNAs were contransfected into NRK-52E cells. As shown in
Figure 9a and b, miR-30e inhibitor alone could
remarkably induce tubular-cell extracellular matrix produc-
tion, whereas UCP2 siRNA transfection could partially block
such effects. Meanwhile, overexpression of UCP2 resisted to
the effects of miR-30e mimic under TGF-b1 treatment
(Figure 9c and d). Hence, UCP2 is required for miR-30e-
mediated tubular-cell extracellular matrix production
stimulated by TGF-b1.
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Inhibition of UCP2-mediated proton leak with genipin
attenuates obstructive nephropathy in mice
Above data have demonstrated the critical role of miR-30e/
UCP2 axis in promoting tubular-cell extracellular matrix
production and renal fibrosis, but then we want to know if
targeting this axis has any beneficial effect on kidney fibrosis.
Genipin is a small molecule derived from the gardenia plant,
which specifically impedes UCP2-mediated proton leak in
mitochondria.26,27 Regarding the critical role of UCP2 in
promoting tubular-cell extracellular matrix production and
kidney fibrosis, it is worthwhile to testing the beneficial effect
of genipin on suppressing renal fibrosis. Compared with
UUO mice treated with vehicle, tubulointerstitial lesion of
UUO mice treated with genipin at 100mg/kg/day exhibited
less kidney tubular damage and interstitial fibrosis
(Figure 10a–h). Genipin administration also reduced the
collagen matrix deposition compared with UUO plus vehicle
group (Figure 10i). Western blot results indicated that
administration of genipin could reduce FN and a-SMA
abundance (Figure 10j and k).
DISCUSSION
We report here that UCP2 was induced in the tubular
epithelial cells with obstructive nephropathy, and UCP2-
knockout mice were resistant to kidney fibrosis. TGF-b1
treatment could induce UCP2 expression, which promoted
TGF-b1-induced EMT in NRK-52E cells. Furthermore, our
study also demonstrated that UCP2 was a direct target
of miR-30e, and targeting UCP2 attenuated tubular-cell
extracellular matrix production and kidney fibrosis.
UCP2 is a mitochondrial carrier protein with homology to
other uncoupling proteins like UCP1 and UCP3.28 It
regulates mitochondrial ATP production by catalyzing the
translocation of protons across the mitochondrial membrane
to reduce the proton-motive force.29,30 Under many diseased
conditions, such as diabetes, atherosclerosis, and liver
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fibrosis, UCP2 expression is upregulated. In our study, both
UCP2 mRNA and protein expression was induced in the
fibrotic kidneys at day 3 after UUO (Figure 1). However, the
protein level of UCP2 almost returned to normal, whereas its
mRNA level reached peak at day 7. The reason is not quite
clear right now. It had been reported that UCP2 expression is
tightly regulated at the translational levels,31 and UCP2
mRNA and protein levels are not often synonymous in many
other tissues.32 In the UUO kidneys, less UCP2 protein at day
7 may be because of protein degradation. However, the
reason for such discrepancy needs more investigation.
The TGF-b1 Smad signaling pathway has a critical role in
driving tubular-cell EMT. The level of TGF-b1 expression in
the obstructed kidneys was found to be similar in wild-type
and UCP2-null mice. But TGF-b1 type I receptor abundance
and phosphorylated Smad3 level in the fibrotic kidney were
reduced in the UCP2 / mice compared with wild-type
mice. It is plausible that UCP2-promoting tubular-cell
extracellular matrix production is associated with Smad
signaling activation.
Macrophage infiltration and activation is thought to be
another important contributor to kidney fibrosis.33–36 In this
study, macrophage infiltration was little, and no kidney
fibrosis was detected in both UCP2þ /þ and UCP2 /
sham kidneys, suggesting that UCP2 has little effect on
macrophage infiltration and kidney fibrosis under normal
conditions. However, at day 7 after UUO, macrophage
infiltration was increased much more in UCP2þ /þ kidneys
compared with those in UCP2 / kidneys. There are two
possible reasons for the less macrophage infiltration in
UCP2 / UUO kidneys: First, it is the consequence of less
kidney fibrosis, which is easily to be understood. Second,
Position 294-301 of Ucp2 3’UTR 5’...GUCUUCUUUCUCAUA– – UGUUUACA...
3’            GAAGGUCAGUUCCUACAAAUGCmmu-miR-30e
1.6
*
*
1.2
0.8
0.4
0
Pre
-co
ntr
ol
WT
2.5
NC
34 kDa UCP2
β-Actin
UCP2
β-Actin
43 kDa
+ +
10 50 100 (nM)
+ + +–
– –
– – –
+
+ +
10 50 100 (nM)
+ + +–
– –
– – –
+
miR-30e mimic
TGF-β1
INNC
34 kDa
43 kDa
miR-30e inhibitor
TGF-β1
INNC
miR-30e inhibitor
TGF-β1
*
*
*
*
# #
#
2
1.5
1
0.5
0
+ +
+ + + +
– –
– ––
10 50 100 (nM)
–
NC
miR-30e mimic
TGF-β1
+ +
+ + + +
– –
– ––
10 50 100 (nM)
–
UC
P2
 e
xp
re
ss
io
n
2.5
2
1.5
1
0.5
0U
CP
2 
ex
pr
es
sio
n
Mut WT Mut
Pre
-m
iR-
30
e
Pre
-co
ntr
ol
Pre
-m
iR-
30
e
An
ti-c
on
tro
l
An
ti-p
re-
mi
R-
30
e
An
ti-c
on
tro
l
An
ti-p
re-
mi
R-
30
e
R
el
at
ive
lu
ci
fe
ra
se
 a
ct
iv
ity
Figure 6 | Uncoupling protein 2 (UCP2) is a direct target of miR-30e. (a) Predicted consequential pairing of UCP2 and miR-30e. (b) Firefly
luciferase reporters containing either wild-type (WT) or mutant (Mut) UCP2 30-untranslated region (UTR) were cotransfected into NRK-52E
cells with pre-miR-30e, pre-control, pre-anti-miR-30e, and pre-anti-control. Luciferase activity was determined at 24 h after transfection.
Real-time PCR analysis (c) and western blot analysis (d) for UCP2 expression in NRK-52E cells (*Po0.05 compared with control; n¼ 3; #Po0.05
vs cells treated with TGF-b1 plus negative control; n¼ 3; mean±s.e.m. as shown). Real-time PCR analysis (e) and western blot analysis
(f) detected UCP2 expression after miR-30e-inhibitor treatment in NRK-52E cells (*Po0.05 compared with inhibitor negative control (INNC);
n¼ 3; mean±s.e.m. as shown).
Kidney International (2013) 84, 285–296 291
L Jiang et al.: miR-30e antagonizes TGF-b1-induced epithelial cell damage by targeting UCP2 bas i c resea rch
1 UUO h3 UUO h12 UUO d1 UUO d3 UUO d7 1.2
1
0.8 *
*
0.6
0.4
0.2
m
iR
-3
0e
 e
xp
re
ss
io
n
0
Sham Day 3 Day 7
UUO
0
–1
–2
Lo
g 2
 
ra
tio
 o
f U
UO
 v
s.
 s
ha
m
–3
–4
–5
m
m
u-
m
iR-
18
5
m
m
u-
m
iR-
18
95
m
m
u-
let
-7a
m
m
u-
let
-7b
m
m
u-
let
-7c
m
m
u-
let
-7d
m
m
u-
let
-7f
m
m
u-
let
-7g
m
m
u-
m
iR-
45
1
m
m
u-
m
iR-
30
e
m
m
u-
m
iR-
70
9
m
m
u-
m
iR-
23
b
m
m
u-
m
iR-
19
3a
m
m
u-
m
iR-
69
0
m
m
u-
m
iR-
72
0
m
m
u-
m
iR-
29
6-5
p
m
m
u-
m
iR-
11
95
m
m
u-
m
iR-
30
d
m
m
u-
m
iR-
49
4
m
m
u-
m
iR-
22
m
m
u-
m
iR-
68
5
m
m
u-
m
iR-
13
0a
m
m
u-
m
iR-
10
7
m
m
u-
m
iR-
32
0
Figure 7 |MiR-30e is downregulated in tubular cells from fibrotic kidneys with obstructive nephropathy. (a) The profile of microRNAs
(miRNAs) expression in the obstructive kidneys at day 3 and 7 after unilateral ureteral occlusion (UUO). (b) Real-time PCR analysis for miR-30e
expression; U6 snRNA was detected as normalization (*Po0.05 compared with sham control; n¼ 5; mean±s.e.m. as shown). (c–f) In situ
hybridization results show that miR-30e was detected in kidney tubular cells from sham control (c) and was almost gone in tubular cells at
day 7 after UUO (d). (e) Sham, scramble. (f) UUO, scramble.
1.0
*
*
a
e f
b c d
*
*
*
*
*
*
0.8
0.6
m
iR
-3
0e
 e
xp
re
ss
io
n
m
iR
-3
0e
 e
xp
re
ss
io
n
m
iR
-3
0e
 e
xp
re
ss
io
n
m
iR
-3
0e
 e
xp
re
ss
io
n
0.4
0.2
1.0
1.2
0.8
0.6
0.4
0.2
0
0 1
TGF-β1 (h)
INNC
170 kDa
130 kDa
43 kDa
43 kDa
FN
E-cadherin
α-SMA
β-Actin
NC + + – ––
170 kDa
130 kDa
43 kDa
43 kDa
miR-30e inhibitor –– 10 50 100 (nM)
FN
E-cadherin
α-SMA
β-Actin
+ + +– +TGF-β1
+ + – ––
miR-30e inhibitor –– 10 50 100 (nM)
+ + +– +TGF-β1
3 6 9 12
0
1.0
0.8
0.6
0.4
0.2
0
– –+ + TGF-β1
pc
DN
A3
pS
ma
d7
NC
m
iR-
30
e m
im
ic
m
iR-
30
e i
nh
ibit
or
INN
C
#
6
8
4
2
0
Figure 8 |MiR-30e regulates NRK-52E-cell extracellular matrix production. (a) Real-time PCR analysis for miR-30e expression after
transforming growth factor-b1 (TGF-b1) (5 ng/ml) treatment in NRK-52E cells; U6 snRNA was detected as normalization (*Po0.05 compared
with control; n¼ 3; mean±s.e.m. as shown). (b) Real-time PCR analysis for miR-30e expression after TGF-b1 treatment in NRK-52E cells
transfected with or without Smad7 expressed plasmid for 12 h (*Po0.05 compared with pcDNA3 transfection; n¼ 3; #Po0.05 vs TGF-b1
treatment in pcDNA3 transfected cells; n¼ 3; mean±s.e.m. as shown). (c) Real-time PCR analysis for miR-30e expression after miR-30e-mimic
treatment; U6 snRNA was detected as normalization (*Po0.05 compared with negative control; n¼ 3; mean±s.e.m. as shown). (d) Real-time
PCR analysis for miR-30e expression after miR-30e-inhibitor treatment; U6 snRNA was detected as normalization (*Po0.05 compared with
negative control; n¼ 3; mean±s.e.m. as shown). (e) Western blot analysis shows fibronectin (FN), a-smooth muscle actin (a-SMA), and
E-cadherin expression after miR-30e-mimic transfection along with TGF-b1 treatment. (f) Western blot analysis shows miR-30e-inhibitor
transfection reduced E-cadherin and increased FN and a-SMA expression.
292 Kidney International (2013) 84, 285–296
bas i c resea rch L Jiang et al.: miR-30e antagonizes TGF-b1-induced epithelial cell damage by targeting UCP2
although UCP2 has no major effect on macrophage
infiltration under normal conditions, its deletion may
disturb macrophage function under diseased conditions,
which may inhibit macrophage infiltration and subsequently
ameliorate kidney fibrosis. We have got some preliminary
data that indicate that transfer of UCP2 / macrophages
ameliorated UUO-induced kidney fibrosis in the mice.
However, the underlying mechanisms are not clear, and
more work is still needed to further clarify the role of
UCP2 / macrophages on kidney fibrosis.
Our studies indicate that UCP2 has a critical role in
tubular-cell extracellular matrix production in renal fibrosis,
but little is known about the regulating mechanisms for
UCP2 induction in the fibrotic kidney. Over the past years,
miRNAs have been shown to regulate many cellular
processes, including EMT. The global analysis of miRNAs
expression reported here revealed that the profiles of
expression of numerous miRNAs were different between
fibrotic kidney and normal kidney (Figure 7). We previously
reported that miR-200 family could regulate TGF-b1-induced
renal tubular EMT through the Smad pathway by targeting
ZEB1 and ZEB2.37 Other groups have found that miR-29 is
involved in collagen expression and renal fibrosis.38,39 In this
study, we found that miR-30e expression was relative
with renal tubular-cell extracellular matrix production by
targeting UCP2.
MiR-30e belongs to miR-30 family, which includes miR-
30a, -30b, -30c, -30d, and -30e. They all have the similar ‘seed
sequence’ in their 50 terminus. MiR-30 family is abundantly
expressed in the kidney, and is required for pronephros
development40 and podocyte homeostasis.41 Hepatic
miR-30b and miR-30c have been previously detected in
CCl4-induced liver fibrosis. Downregulated miR-30 family
members promote EMT of epithelial thyroid cells in
anaplastic thyroid carcinomas42 and cultured fetal human
pancreatic islets in pancreatitis.25 Our studies found that
miR-30e expression was dramatically decreased in fibrotic
kidney, whereas miR-30d displayed slight changes, and miR-
30a, -30b, and -30c were not significantly altered. Although
miR-30 family members have a similar sequence, their genes
are localized in different chromosomes. It is possible
that the gene-expression pattern may be dependent on
different stimuli. We also found that TGF-b1 was able to
downregulate miR-30e in NRK-52E cells, but the effect of
TGF-b1 on miR-30e expression could be partially blocked by
Smad7 transfection. Therefore, downregulation of the miR-
30e by TGF-b1 at least partially depends on the intracellular
Smad signaling activation. By overexpression or knockdown
of miR-30e expression in NRK-52E cells, we found that
miR-30e was critical for TGF-b1-induced tubular epithelial
injury. Taken together, our results indicate that miR-30e
downregulation could be an important facilitator for
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TGF-b1-induced tubular-cell extracellular matrix production
in renal fibrosis.
miR-30e is markedly reduced during renal fibrosis process,
and the expression of UCP2 is upregulated. This is in line
with the TargetScan prediction that UCP2 may be the target
of miR-30e. Here our current study provides multiple lines of
evidence that UCP2 is regulated by miR-30e. First, the
expression of miR-30e was inversely related to the amount of
UCP2 mRNA and protein in UUO model of renal fibrosis
and NRK-52E cells stimulated by TGF-b1. Second, in NRK-
52E cells, miR-30e knockdown increased UCP2 levels both at
the mRNA and protein levels and was accompanied by the
phenotypic change similar to TGF-b1 treatment. Third,
overexpression of miR-30e resulted in a significant down-
regulation of UCP2, and resisted to TGF-b1-induced
epithelial cell phenotype changes. Fourth, analyses of the
luciferase reporter carrying the UCP2 30-UTR indicate that
miR-30e directly interacts with this sequence, and the
putative miR-30e-binding sites are essential for miR-30e
regulation. Fifth, knockdown UCP2 expression could block
the effects of miR-30e inhibitor on promoting tubular-cell
extracellular matrix production.
As a member of a family of anion-carrier proteins
expressed in the inner membrane of the mitochondria,
UCP2, by virtue of its proton-leak activity, decreases the
generation of ATP and therefore causes tubular cell EMT.
Interestingly, decreased miR-30e expression has been found
in tubular epithelial cells of fibrotic kidney. These clues
lead to pinpoint the role of miR-30e, targeting UCP2 as a
heretofore hidden disease regulator of chronic renal
diseases. Furthermore, kidney fibrosis was largely inhibited
by treatment with genipin, which is a UCP2 blocker. In
summary, it is concluded that miR-30e/UCP2 axis has an
important role in mediating TGF-b1-induced epithelial-cell
extracellular matrix production and kidney fibrosis. Targeting
this pathway may shed a new light for the future fibrotic
kidney diseases therapy.
MATERIALS AND METHODS
Animal models
Colonies of homozygous UCP2-knockout (UCP2–/–) mice
were kindly provided by Professor Chenyu Zhang of Nanjing
University, China.43 UCP2 / mice were generated on C57BL/6J
background. The experiments were performed on male UCP2 /
mice with an average age of 8–10 weeks. Age- and gender-matched
C57BL/6J mice (UCP2þ /þ ) were used as wild-type control
throughout the experiments. There was no statistical difference as
to the body weight, kidney weight, blood urine nitrogen (BUN), and
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serum creatinine between control and UCP2 / mice. For UUO
experiment, wild-type and UCP2 / mice were randomly
assigned into two groups with five mice for sham and UUO. A
well-characterized mouse UUO model was performed as previously
reported.44 The mice were killed at day 3 and 7 after UUO.
Cell culture and treatment
Rat renal tubular epithelial cells (NRK-52E) were obtained from
American Type Culture Collection (Manassas, VA). Cells were
cultured as previous described.45 Human Recombinant TGF-b1
(5 ng/ml) (cat no.: 100-B-010-CF; R&D, Minneapolis, MN) was
added to the serum-free medium for various periods of time.
MiR-30e mimic, miR-30e inhibitor, UCP2 siRNA (GenePharma,
Shanghai, China), UCP2 plasmid (provided by professor Chenyu
Zhang), and Smad7 plasmid (obstained from Invitrogen, Grand
Island, NY) were transfected into NRK-52E cells using Lipo-
fectamine 2000 reagent (Invitrogen) according to the manufacturer’s
instructions.
Immunofluorescent and immunohistochemical staining
Immunofluorescent staining of culture NRK-52E cells and
immunohistochemical staining of kidney sections was performed
by using an established protocol.45 Cell-culture coverslips or kidney
sections were immunostained with primary antibodies against FN
(cat no.: F3648; Sigma, St Louis, MO), a-SMA (cat no.: a5228,
Sigma), E-cadherin (cat no.: 610181; BD Biosciences, San Jose, CA),
and F4/80 (cat no.:14-4801-81; ebioscience, San Diego, CA).
Paraffin-embedded kidney tissue sections were stained with anti-
UCP2 antibody (cat no.:ab77363; Abcam, Cambridge, MA) and
Ki-67(cat no. ab15580; Abcam). Slides were viewed with a Nikon
Eclipse 80i Epi-fluorescence microscope equipped with a digital
camera (DS-Ri1; Nikon, New York, NY).
Western blot analysis
Western blot analysis for specific protein expression was performed
according to an established procedure.45 The primary antibodies
used were as follows: anti-FN, anti-a-SMA, anti-E-cadherin,
and anti-UCP2. Quantification was performed by measuring the
intensity of the signals with the aid of National Institutes of Health
Image software package.
RNA isolation and microarray analysis
Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s guide. RNA labeling and
hybridization on miRNA microarray chips were conducted as
previously described.46,47 Briefly, 50 mg of total RNA was purified
using the mirVANA miRNA isolation kit (Ambion, Austin, TX) to
enrich small RNA fraction. Purified RNA was labeled with
fluorescein, and hybridization was carried out on the CapitalBio
Mammalian miRNA Array V 3.0 (CapitalBio, Beijing, China)
containing 509 probes in triplicate. The miRNA microarray data
have been deposited into Gene Expression Omnibus (GEO accession
number GSE13840) and can be prepared in a fully minimum
information about a microarray experiment compliant manner.
PCR
cDNAs were synthesized using ReverTra Kit (Toyobo, Osaka, Japan)
according to the manufacturer’s instructions. Gene expression was
measured using cDNA, real-time PCR Master Mix Reagents (Roche,
Mannheim, Germany), and a set of gene primers with 7300
real-time PCR system (Supplementary Table S1 online) (Applied
Biosystems, Foster City, CA). To detect miRNA expression level,
miScript PCR system (Qiagen, Valencia, CA) was used for
quantification of miRNA transcripts. For real-time PCR analysis,
the relative amount of miRNA or gene to internal control was
calculated by using the equation 2DCT, in which DCT¼CT gene
CT control.
Plasmid construction and luciferase assay
The entire mouse UCP2 30-UTR segment was amplified by PCR.
The PCR products were inserted into the p-MIR-report plasmid. For
luciferase reporter assay, 1 mg firefly luciferase reporter plasmid,
0.5 mg b-galactosidase expression vector (Ambion), and equal
amounts (200 pmol) of pre-miR-30e, anti-miR-30e, or scrambled
negative control RNA were transfected into cells. At 24 h after
transfection, cells were assayed using luciferase assay kits (Promega,
Madison, WI).
In situ hybridization
In situ hybridization was used to identify the localization of miR-30e
in normal and UUO kidneys following the manufacturer’s
instructions (Exiqon, Woburn, MA). Briefly, the slides were
hybridized with double-digoxygenin-labeled, lucked nucleic acid
miR-30e probe, locked nucleic acid scrambled miRNA probe, lucked
nucleic acid U6 snRNA probe, and lucked nucleic acid miR-126
probe (positive control). The slides was mounted with mounting
medium and viewed under light microscope (Nikon Eclipse 80i).
Statistical analysis
Statistical analysis was performed using SigmaStat software (Jandel
Scientific Software, San Rafael, CA).Comparison between groups
was made using one-way analysis of variance, followed by the
Student–Newman–Keuls test. Po0.05 was considered statistically
significant.
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